Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

NDS are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021. © Medical Sciences Division and John Cairns

The  Oxford-Wolfson-Marriott-Patel Scholarship is in partnership with Wolfson College, where the successful candidate will be placed, and will cover course fees at the Home/ROI level along with a stipend for living costs at the standard Research Council rate (£15,285 pa for 2020/21).

The award is made possible by a philanthropic legacy to Wolfson from the late Dr Francis Marriott and a donation from the University's Graduate Scholarship Matched Fund, along with an equal contribution from NDS. It is named in memory of Dr Nilay Patel, who was a Consultant Urological Surgeon and Senior Fellow in NDS before his sudden passing in 2014. 

To be eligible for the scholarship, candidates must apply by 8 January 2021. There is no separate application required for this award, and the successful candidate will be selected based on academic merit. When awarding the scholarship, preference will be given to applicants who have listed Wolfson as their first-choice College when two (or more) candidates are of equal academic merit.

Further information and how to apply can be found on the Wolfson College website. 

Hear from Dr Katherine Hurst, who was awarded the first Oxford-Wolfson-Marriott-Patel Graduate Scholarship.

Similar stories

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

NDS project awarded Public Engagement Seed Funding 2020-21

Awards and appointments Public engagement

Seven projects from the Medical Sciences Division, including a project from the Nuffield Department of Surgical Sciences, have received funding in the 2020-21 round of the Public Engagement with Research Seed Fund for innovative projects to engage the public with medical research.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

JNDS: new issue out now

Department Publication

Journal of the Nuffield Department of Surgical Sciences (JNDS) has published its next issue, featuring top case reports written by University of Oxford medical students during their clinical studies.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.